Aptose Biosciences

Targeted small molecules for the treatment of acute myeloid leukemia and high-risk myelodysplastic syndromes.

placeMississauga, Ontario, Canada calendar_todayFounded 1986 groups31 employees language aptose.com

Registered entities

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Bank & private debt133%
Other / undisclosed133%
Coming soon